XML 69 R60.htm IDEA: XBRL DOCUMENT v3.25.0.1
Acquisitions - Additional Information (Detail) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 02, 2024
Oct. 02, 2023
Apr. 17, 2023
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Business Acquisition [Line Items]            
Goodwill       $ 1,030,995 $ 987,120 $ 855,513
Metenova Holding AB            
Business Acquisition [Line Items]            
Cash consideration   $ 164,500        
Shares issued for business acquisition   52,299        
Value of common stock issued   $ 172,600        
Net liabilities assumed   1,900        
Fair value of acquired finite lived intangible assets   58,800        
Goodwill       115,722 115,700  
Intangible Asset Residual Value   115,700        
Transaction costs       6,500    
Metenova Holding AB | Developed technology            
Business Acquisition [Line Items]            
Fair value of acquired finite lived intangible assets       $ 44,377    
Weighted Average Useful Life (in years)       15 years    
Metenova Holding AB | Common Stock            
Business Acquisition [Line Items]            
Value of common stock issued   $ 8,100        
FlexBiosys, Inc.            
Business Acquisition [Line Items]            
Business combination date of acquistion     Apr. 17, 2023      
Cash consideration     $ 29,000      
Deposited in escrow for future payments,     $ 6,300      
Shares issued for business acquisition     31,415      
Value of common stock issued     $ 41,000      
Net liabilities assumed     14,100      
Fair value of acquired finite lived intangible assets     12,600      
Goodwill       $ 14,321 $ 14,300  
Intangible Asset Residual Value     14,300      
Transaction costs       900    
Business combination contingent consideration     6,600 3,300    
FlexBiosys, Inc. | Developed technology            
Business Acquisition [Line Items]            
Fair value of acquired finite lived intangible assets       $ 9,860    
Weighted Average Useful Life (in years)       16 years    
FlexBiosys, Inc. | Common Stock            
Business Acquisition [Line Items]            
Value of common stock issued     $ 5,400      
Tantti Laboratory Inc.            
Business Acquisition [Line Items]            
Cash consideration $ 55,100          
Value of common stock issued 74,800          
Net liabilities assumed 1,200          
Fair value of acquired finite lived intangible assets 28,900          
Weighted Average Useful Life (in years)       15 years    
Goodwill       $ 47,105    
Intangible Asset Residual Value 47,100          
Transaction costs       1,600    
Business combination contingent consideration $ 19,700          
Tantti Laboratory Inc. | Developed technology            
Business Acquisition [Line Items]            
Fair value of acquired finite lived intangible assets       $ 28,910